Literature DB >> 33951119

The Interrelationship Among Non-Alcoholic Fatty Liver Disease, Colonic Diverticulosis and Metabolic Syndrome.

Tamara Milovanovic1, Ivana Pantic2, Sanja Dragasevic3, Sofija Lugonja4, Igor Dumic5, Mirjana Rajilic-Stojanovic6.   

Abstract

Non-alcoholic fatty liver disease and colonic diverticulosis are widespread, obesity-related diseases. It has recently become clear that non-alcoholic fatty liver disease is a systemic disease and may play a key role in metabolic syndrome; therefore, the term metabolic-dysfunction-associated fatty liver disease has been introduced in the literature. Excess visceral adipose tissue is an important predictor of complications in both non-alcoholic fatty liver disease and colonic diverticulosis. Current evidence suggests that intestinal dysbiosis may be involved in the development of both non-alcoholic fatty liver disease and colonic diverticulosis, and that metabolic syndrome is a consequence rather than a cause of this complex relationship. In this review, our aim was to assess the current knowledge of the complex interplay between metabolic syndrome, non-alcoholic fatty liver disease, and colonic diverticulosis.

Entities:  

Mesh:

Year:  2021        PMID: 33951119     DOI: 10.15403/jgld-3308

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  12 in total

1.  Macronutrient Intake in Adults Diagnosed with Metabolic Syndrome: Using the Health Examinee (HEXA) Cohort.

Authors:  Hyerim Park; Anthony Kityo; Yeonjin Kim; Sang-Ah Lee
Journal:  Nutrients       Date:  2021-12-14       Impact factor: 5.717

2.  Triglyceride Glucose-Waist Circumference Is Superior to the Homeostasis Model Assessment of Insulin Resistance in Identifying Nonalcoholic Fatty Liver Disease in Healthy Subjects.

Authors:  Hwi Seung Kim; Yun Kyung Cho; Eun Hee Kim; Min Jung Lee; Chang Hee Jung; Joong-Yeol Park; Hong-Kyu Kim; Woo Je Lee
Journal:  J Clin Med       Date:  2021-12-23       Impact factor: 4.241

3.  Nonalcoholic Fatty Liver Disease Is a Precursor of New-Onset Metabolic Syndrome in Metabolically Healthy Young Adults.

Authors:  Jeong-Ju Yoo; Eun Ju Cho; Goh Eun Chung; Young Chang; Yuri Cho; Sang-Hyun Park; Su-Min Jeong; Bo-Yeon Kim; Dong Wook Shin; Yun Joon Kim; Jung-Hwan Yoon; Kyungdo Han; Su Jong Yu
Journal:  J Clin Med       Date:  2022-02-11       Impact factor: 4.241

Review 4.  The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.

Authors:  Marcin Kosmalski; Sylwia Ziółkowska; Piotr Czarny; Janusz Szemraj; Tadeusz Pietras
Journal:  J Clin Med       Date:  2022-03-02       Impact factor: 4.241

5.  Reducing Metabolic Syndrome through a Group Educational Intervention Program in Adults with Obesity: IGOBE Program.

Authors:  Cristina Tejera; Cristina Porca; Gemma Rodriguez-Carnero; Paula Andújar; Felipe F Casanueva; Diego Bellido; Ana B Crujeiras
Journal:  Nutrients       Date:  2022-03-03       Impact factor: 5.717

6.  Conservative Management of Complicated Colonic Diverticulitis in Early and Late Elderly.

Authors:  Gennaro Perrone; Mario Giuffrida; Elena Bonati; Gabriele Luciano Petracca; Antonio Tarasconi; Gianluca Baiocchi; Fausto Catena
Journal:  Medicina (Kaunas)       Date:  2021-12-24       Impact factor: 2.430

7.  Colonic Diverticulosis and Non-Alcoholic Fatty Liver Disease: Is There a Connection?

Authors:  Ivana Pantic; Sofija Lugonja; Nina Rajovic; Igor Dumic; Tamara Milovanovic
Journal:  Medicina (Kaunas)       Date:  2021-12-27       Impact factor: 2.430

Review 8.  Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism.

Authors:  Tae Hyun Kim; Dong-Gyun Hong; Yoon Mee Yang
Journal:  Biomedicines       Date:  2021-12-14

Review 9.  Microbiota in Pancreatic Diseases: A Review of the Literature.

Authors:  Tommaso Schepis; Sara S De Lucia; Enrico C Nista; Vittoria Manilla; Giulia Pignataro; Veronica Ojetti; Andrea Piccioni; Antonio Gasbarrini; Francesco Franceschi; Marcello Candelli
Journal:  J Clin Med       Date:  2021-12-17       Impact factor: 4.241

10.  Selecting the Target Population for Screening of Hepatic Fibrosis in Primary Care Centers in Korea.

Authors:  Huiyul Park; Eileen L Yoon; Mimi Kim; Seon Cho; Jung-Hwan Kim; Dae Won Jun; Eun-Hee Nah
Journal:  J Clin Med       Date:  2022-03-08       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.